会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 30. 发明申请
    • METHODS FOR MEASURING CHOLESTEROL METABOLISM AND TRANSPORT
    • 测量胆固醇代谢和运输的方法
    • WO2006119438A2
    • 2006-11-09
    • PCT/US2006/017167
    • 2006-05-03
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIAHELLERSTEIN, Marc, K.
    • HELLERSTEIN, Marc, K.
    • A61K51/00A61K49/00
    • A61K51/0493
    • The present invention relates to biochemical methods for determining reverse cholesterol transport (RCT). Specifically, the three components of RCT (efflux, plasma, and excretion) are measured in vivo by administering an isotope-labeled cholesterol or cholesterol-related molecule or cholesterol-related complex, and then measuring the dilution or appearance of isotopes in the various cholesterol or cholesterol-related molecules or cholesterol-related complexes, as well as recovery in sterol end-products, that are part of RCT. A parameter of Global RCT flux, representing for the first time in living organisms that combined rate of cholesterol efflux from tissues into blood and excretion from blood out of the body, is generated. Such methods find use in drug discovery and development, diagnosis and prognosis of atherosclerosis and other blood vessel diseases and conditions, the selection of proper doses for treating disease, and selecting subjects for therapies targeting RCT flux.
    • 本发明涉及用于测定反向胆固醇转运(RCT)的生物化学方法。 具体来说,通过施用同位素标记的胆固醇或胆固醇相关分子或与胆固醇相关的复合物在体内测量RCT(流出,血浆和排泄物)的三个组分,然后测量各种胆固醇中同位素的稀释或外观 或胆固醇相关分子或胆固醇相关复合物,以及作为RCT一部分的甾醇终产物的回收。 产生全球RCT通量的参数,这是生物体中首次出现胆固醇从组织向血液中流出并将血液排出体外的结合率。 这些方法可用于药物发现和开发,动脉粥样硬化和其他血管疾病和病症的诊断和预后,选择用于治疗疾病的适当剂量,并选择靶向RCT通量的疗法的受试者。